Cita APA

Petta, S., Kim, K., Targher, G., Romeo, S., Sookoian, S. C., Zheng, M., . . . Valenti, L. (2025). Focus on Semaglutide 2.4 mg/week for the Treatment of Metabolic Dysfunction‐Associated Steatohepatitis. Web

Citación estilo Chicago

Petta, Salvatore, KyeongJin Kim, Giovanni Targher, Stefano Romeo, Silvia Cristina Sookoian, Ming?Hua Zheng, Alessio Aghemo, and Luca Valenti. Focus On Semaglutide 2.4 mg/week for the Treatment of Metabolic Dysfunction‐Associated Steatohepatitis. 2025.

Cita MLA

Petta, Salvatore, et al. Focus On Semaglutide 2.4 mg/week for the Treatment of Metabolic Dysfunction‐Associated Steatohepatitis. 2025.